105 related articles for article (PubMed ID: 24895416)
1. Preconditioning actions of aldosterone through p38 signaling modulation in isolated rat hearts.
Yoshino T; Nagoshi T; Anzawa R; Kashiwagi Y; Ito K; Katoh D; Fujisaki M; Kayama Y; Date T; Hongo K; Yoshimura M
J Endocrinol; 2014 Aug; 222(2):289-99. PubMed ID: 24895416
[TBL] [Abstract][Full Text] [Related]
2. Preconditioning in globally ischemic isolated rat hearts: effect on function and metabolic indices of myocardial damage.
Arad M; de Jong JW; de Jonge R; Huizer T; Rabinowitz B
J Mol Cell Cardiol; 1996 Dec; 28(12):2479-90. PubMed ID: 9004164
[TBL] [Abstract][Full Text] [Related]
3. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
4. The role of NO in ischemia/reperfusion injury in isolated rat heart.
Andelová E; Barteková M; Pancza D; Styk J; Ravingerová T
Gen Physiol Biophys; 2005 Dec; 24(4):411-26. PubMed ID: 16474186
[TBL] [Abstract][Full Text] [Related]
5. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
[TBL] [Abstract][Full Text] [Related]
6. Ischemic preconditioning fails to confer additional protection against ischemia-reperfusion injury in the hypothyroid rat heart.
Mourouzis I; Dimopoulos A; Saranteas T; Tsinarakis N; Livadarou E; Spanou D; Kokkinos AD; Xinaris C; Pantos C; Cokkinos DV
Physiol Res; 2009; 58(1):29-38. PubMed ID: 18198989
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?
Chai W; Garrelds IM; de Vries R; Danser AH
Hypertension; 2006 Apr; 47(4):665-70. PubMed ID: 16490840
[TBL] [Abstract][Full Text] [Related]
8. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
9. Experimental conditions determine effects of ascorbic acid on reperfusion injury: comparison of tissue damage with hemodynamic parameters in rat isolated hearts.
Doppelfeld IS; Parnham MJ
Methods Find Exp Clin Pharmacol; 1992; 14(6):419-30. PubMed ID: 1469951
[TBL] [Abstract][Full Text] [Related]
10. Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts.
Bouwman RA; Vreden MJ; Hamdani N; Wassenaar LE; Smeding L; Loer SA; Stienen GJ; Lamberts RR
Eur J Pharmacol; 2010 Nov; 647(1-3):132-8. PubMed ID: 20816812
[TBL] [Abstract][Full Text] [Related]
11. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury.
Vessey DA; Kelley M; Li L; Huang Y; Zhou HZ; Zhu BQ; Karliner JS
Med Sci Monit; 2006 Oct; 12(10):BR318-24. PubMed ID: 17006394
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
13. CREB activation and ischaemic preconditioning.
Marais E; Genade S; Lochner A
Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester, but not ischemic preconditioning, activates protein kinase D in the rat heart.
Brooks G; Goss MW; Rozengurt E; Galiñanes M
J Mol Cell Cardiol; 1997 Aug; 29(8):2273-83. PubMed ID: 9281458
[TBL] [Abstract][Full Text] [Related]
15. Phenylephrine induces early and late cardioprotection through mitochondrial permeability transition pore in the isolated rat heart.
Naderi R; Imani A; Faghihi M; Moghimian M
J Surg Res; 2010 Nov; 164(1):e37-42. PubMed ID: 20850771
[TBL] [Abstract][Full Text] [Related]
16. Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target.
Nagy N; Shiroto K; Malik G; Huang CK; Gaestel M; Abdellatif M; Tosaki A; Maulik N; Das DK
J Mol Cell Cardiol; 2007 May; 42(5):981-90. PubMed ID: 17397860
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
19. Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats.
Chen LB; Liu T; Wu JX; Chen XF; Wang L; Fan CL; Gao PJ; Higashino H; Lee WH; Yuan WJ; Chen H
Acta Pharmacol Sin; 2003 Nov; 24(11):1077-82. PubMed ID: 14627488
[TBL] [Abstract][Full Text] [Related]
20. Benzolamide perpetuates acidic conditions during reperfusion and reduces myocardial ischemia-reperfusion injury.
Ciocci Pardo A; Díaz RG; González Arbeláez LF; Pérez NG; Swenson ER; Mosca SM; Alvarez BV
J Appl Physiol (1985); 2018 Aug; 125(2):340-352. PubMed ID: 29357509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
